COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Cantab Biopharmaceuticals develops "biosuperior" biologics from Cambridge, UK, advancing haematology candidates (via internal development and third‑party platforms) toward Phase I/II trials and partnering for later-stage development.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor